PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.\', \'Division of Infectious Diseases, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain. Electronic address: acabello@fjd.es.\', \'Department of Pneumology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.\', \'Department of Pharmacy, Fundación Jiménez Díaz, Spain.\', \'Department of Microbiology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.\', \'Department of Pathology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.\', \'Department of Rheumatology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(20)32249-910.1016/j.ijid.2020.10.045
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33115682
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all